Literature DB >> 11134268

Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9.

D L Thomas1, J Schaack, H Vogel, R Javier.   

Abstract

Among oncogenic adenoviruses, human adenovirus type 9 (Ad9) is unique in eliciting exclusively estrogen-dependent mammary tumors in rats and in not requiring viral E1 region transforming genes for tumorigenicity. Instead, studies with hybrid viruses generated between Ad9 and the closely related nontumorigenic virus Ad26 have roughly localized an Ad9 oncogenic determinant(s) to a segment of the viral E4 region containing open reading frame 1 (E4-ORF1), E4-ORF2, and part of E4-ORF3. Although subsequent findings have shown that E4-ORF1 codes for an oncoprotein essential for tumorigenesis by Ad9, it is not known whether other E4 region functions may similarly play a role in this process. We report here that new results with Ad9/Ad26 hybrid viruses demonstrated that the minimal essential Ad9 E4-region DNA sequences include portions of both E4-ORF1 and E4-ORF2. Investigations with Ad9 mutant viruses additionally showed that the E4-ORF1 protein and certain E4-ORF2 DNA sequences are necessary for Ad9-induced tumorigenesis, whereas the E4-ORF2 and E4-ORF3 proteins are not. In fact, the E4-ORF3 protein was found to antagonize this process. Also pertinent was that certain crucial nucleotide differences between Ad9 and Ad26 within E4-ORF1 and E4-ORF2 were found to be silent with respect to the amino acid sequences of the corresponding proteins. Furthermore, supporting a prominent role for the E4-ORF1 oncoprotein in Ad9-induced tumorigenesis, an E1 region-deficient Ad5 vector that expresses the Ad9 but not the Ad26 E4-ORF1 protein was tumorigenic in rats and, like Ad9, promoted solely mammary tumors. These findings argue that the E4-ORF1 oncoprotein is the major oncogenic determinant of Ad9 and that an undefined regulatory element(s) within the E4 region represents a previously unidentified second function likewise necessary for tumorigenesis by this virus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134268      PMCID: PMC113951          DOI: 10.1128/JVI.75.2.557-568.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases.

Authors:  B J Blencowe
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.

Authors:  B A Glaunsinger; S S Lee; M Thomas; L Banks; R Javier
Journal:  Oncogene       Date:  2000-11-02       Impact factor: 9.867

3.  Human adenovirus type 9-induced rat mammary tumors.

Authors:  R Javier; K Raska; G J Macdonald; T Shenk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Adenovirus type 9-induced tumorigenesis in the rat mammary gland related to sex hormonal state.

Authors:  J Ankerst; N Jonsson
Journal:  J Natl Cancer Inst       Date:  1989-02-15       Impact factor: 13.506

6.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

7.  Induction of mammary fibroadenomas in rats by adenovirus type 9.

Authors:  J Ankerst; N Jonsson; L Kjellén; E Norrby; H O Sjögren
Journal:  Int J Cancer       Date:  1974-03-15       Impact factor: 7.396

8.  Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control.

Authors:  T Suzuki; Y Ohsugi; M Uchida-Toita; T Akiyama; M Yoshida
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

9.  Requirement for the adenovirus type 9 E4 region in production of mammary tumors.

Authors:  R Javier; K Raska; T Shenk
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

10.  Physical mapping of a large-plaque mutation of adenovirus type 2.

Authors:  G Chinnadurai; S Chinnadurai; J Brusca
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

View more
  11 in total

1.  Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein.

Authors:  Kristopher K Frese; Siu Sylvia Lee; Darby L Thomas; Isabel J Latorre; Robert S Weiss; Britt A Glaunsinger; Ronald T Javier
Journal:  Oncogene       Date:  2003-02-06       Impact factor: 9.867

2.  A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles.

Authors:  Sang-Hyuk Chung; Kristopher K Frese; Robert S Weiss; B V Venkataram Prasad; Ronald T Javier
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

3.  Hijacking Dlg1 for oncogenic phosphatidylinositol 3-kinase activation in human epithelial cells is a conserved mechanism of human adenovirus E4-ORF1 proteins.

Authors:  Manish Kumar; Kathleen Kong; Ronald T Javier
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

4.  Viral PDZ Binding Motifs Influence Cell Behavior Through the Interaction with Cellular Proteins Containing PDZ Domains.

Authors:  Carlos Castaño-Rodriguez; Jose M Honrubia; Javier Gutiérrez-Álvarez; Isabel Sola; Luis Enjuanes
Journal:  Methods Mol Biol       Date:  2021

5.  Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2.

Authors:  B A Glaunsinger; R S Weiss; S S Lee; R Javier
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

6.  Characterization of human adenovirus 35 and derivation of complex vectors.

Authors:  Duncan McVey; Mohammed Zuber; Damodar Ettyreddy; Christopher D Reiter; Douglas E Brough; Gary J Nabel; C Richter King; Jason G D Gall
Journal:  Virol J       Date:  2010-10-19       Impact factor: 4.099

7.  Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression.

Authors:  Kathleen Kong; Manish Kumar; Midori Taruishi; Ronald T Javier
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

Review 8.  Cell polarity proteins: common targets for tumorigenic human viruses.

Authors:  R T Javier
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

9.  The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase.

Authors:  Kathleen Kong; Manish Kumar; Midori Taruishi; Ronald T Javier
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

10.  Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation.

Authors:  Travis B McMurphy; Wei Huang; Run Xiao; Xianglan Liu; Nikhil V Dhurandhar; Lei Cao
Journal:  Diabetes       Date:  2016-11-30       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.